By Jenny Thayer, BioBridges’ SVP Medical, Regulatory, Scientific Communications While a quality control (QC) review of a regulatory document is essential, it is often the easiest step to skip or...
Working in life sciences is exciting because of the ever-changing landscape. In a constantly evolving industry, new regulations and legislation continuously emerge. As a life sciences professional, staying current is...
As an established pharmaceutical company focused on neurological diseases was preparing for a submission and realized that they had not fully completed the necessary quality GMP and GCP activities during the course of the program.
A virtual company submitted their first IND and needed an effective and nimble project team to oversee their clinical program, develop clinical documents for regulatory submissions, and support overall business development.
A premier academic institution and research center with critical partnerships with large pharma, biotech, and device organizations recognized a gap: they required industry experience to effectively collaborate with their sponsor partners. Additionally, our client faced the emerging challenges of managing the ever-changing considerations resulting from COVID-19, which were amplified due to their lack of experience with a remote work force.